Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ACARBOSE 25 MG TABLET

Acarbose
$0.1539per EA

Strength

25 mg/1

Manufacturer

Hikma Pharmaceuticals USA Inc.

NDC

00054014025

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ACARBOSE

Approval Type

Generic (ANDA)

FDA Application

ANDA078470

On Market Since

5/7/2008

Pharmacological Classes

alpha Glucosidase Inhibitors
alpha-Glucosidase Inhibitor

Price History

1W

0.0%

1M

+4.9%

3M

+7.5%

6M

-2.8%

1Y

-11.1%

3Y

-5.6%

5Y

-15.8%

All

-52.9%

Generic Alternatives

1 alternative • Same active ingredient

ACARBOSE 25 MG TABLET
Generic
23155014701•Heritage Pharmaceuticals Inc.
$0.1539

Related Drugs

Same classification

ACARBOSE 25 MG TABLET
Generic
62135045390•Chartwell RX LLC
$0.1539
per EA
ACARBOSE 25 MG TABLET
Generic
64380075806•Strides Pharma Inc.
$0.1539
per EA
ACARBOSE 50 MG TABLET
Generic
62135045490•Chartwell RX LLC
$0.1654
per EA
ACARBOSE 50 MG TABLET
Generic
64380075906•Strides Pharma Inc.
$0.1654
per EA
ACARBOSE 100 MG TABLET
Generic
62135045590•Chartwell RX LLC
$0.2308
per EA
ACARBOSE 100 MG TABLET
Generic
64380076006•Strides Pharma Inc.
$0.2308
per EA
MIGLITOL 25 MG TABLET
Generic
69367030301•Westminster Pharmaceuticals LLC
$1.7545
per EA
MIGLITOL 50 MG TABLET
Generic
69367030401•Westminster Pharmaceuticals LLC
$1.7640
per EA
MIGLITOL 100 MG TABLET
Generic
69367030501•Westminster Pharmaceuticals LLC
$2.0312
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy